Fronteras que dan forma a la próxima generación de predicción de productos de transformación y evaluación

Paul Löffler1, Emma L Schymanski2, Henning Henschel3

  • 1Department of Aquatic Sciences and Assessment, Swedish University of Agricultural Sciences (SLU), P.P. Box 7050, SE-750 07 Uppsala, Sweden.

PubMed
Resumen

La caracterización de los productos de transformación (PT) es vital para la seguridad ambiental. Los métodos computacionales ayudan a predecir la formación de TP y la toxicidad, pero requieren más datos e interpretación de expertos para una evaluación de riesgos confiable.

Videos de Conceptos Relacionados

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K